Low levels of the survival motor neuron protein (SMN) cause the disease spinal muscular atrophy (SMA). A primary characteristic of this disease is motoneuron dysfunction and paralysis. Understanding why motoneurons are affected by low levels of this protein will lend insight into this disease and to motoneuron biology in general.
Introduction
Proper neuronal development is critical for subsequent nervous system function. It is becoming increasingly evident that nervous system disorders in children and adults such as schizophrenia, autism and Rett syndrome can arise from defects in nervous system development (1-3). Problems in developmental neuronal migration and synapse formation, for example, can lead to altered connectivity in the nervous system and therefore affect brain function. These studies stress that an understanding of how neurons develop within a disease context can reveal information about the disorder.
Spinal muscular atrophy (SMA) is a motoneuron disease that in over half of the cases is diagnosed in infants soon after birth. It is caused by low levels of the survival motor neuron protein (SMN), a ubiquitously expressed protein present in all cells types that have been examined (4, 5). SMA is clinically characterized by motoneuron dysfunction, paralysis, and in severe cases premature death. SMN is a ubiquitously expressed protein and decreased protein levels in animal models affects other cells and organs in addition to motoneurons (6). We had previously shown in a zebrafish genetic model of SMA that motoneuron development is adversely affected by low levels of Smn (7). This included decreased axonal arborization leading to fewer neuromuscular junction synapses and decreased animal movement. Motoneuron dendrite formation was also less robust in these animals. We also showed that the need for SMN was early during motoneuron development well before axon and dendrite formation suggesting a role for SMN in motoneurons throughout development. Since SMN is ubiquitously expressed it is not known whether SMN is needed autonomously for proper motoneuron development. In addition, it is important to know how defects in by guest on November 7, 2016 http://hmg.oxfordjournals.org/ Downloaded from 4 one cell type, can affect other cellular interactions. This not only reveals the primary defect, but also the ramifications of this deficit.
We are also interested in addressing where SMN is localized in neurons as this can provide insight into its function. SMN is present in the cell body and nucleus in all cells. However, in neurons SMN is also present in axons. Work in cultured neurons has shown that both endogenous and expressed transgenic SMN is transported into axons by active transport (8-11). There is also evidence from fixed tissue that SMN is present in axons (12, 13). However, this has not been analyzed in vivo during the period of motoneuron development and axonal outgrowth and thus the function of SMN in axons remains unclear.
Here we examine cellular components of the motor circuit in an SMA animal model and find that other cell types beyond the motoneuron are disrupted. Using spatial transgenic lines to test cell autonomy, we find these defects are motoneuron autonomous and adding human SMN to motoneurons completely rescues the developmental defect. These data indicate that aberrant motoneuron development caused by low levels of Smn results not only in motoneuron deficits, but defects in additional aspects of the motor circuit. Importantly, we also show that SMN is present in motor axons, but only during the period of robust axonal outgrowth and arborization suggesting a need for SMN function in motor axons during development. 
Results

Generation of transgenic lines expressing SMN in zebrafish motoneurons
To analyze the role of SMN in motoneuron development, we generated a transgenic zebrafish line expressing RFP-tagged human SMN under the control of the zebrafish mnx1/hb9 promoter, which drives expression in motoneurons (14) . We had previously shown that the zebrafish heat shock promoter 70 (hsp70) can enhance the expression levels of the mnx1 promoter (15) and here we used hsp70 to increase expression of human SMN under the mnx1 promoter. We generated three unique transgenic lines (os44, os45, and os46) that expressed different levels of RFP-SMN as revealed by analyzing protein levels at 2 dpf ( Fig.1 A, B) . Tg(mnx1:1.5:hsp70:RFP-Hsa.SMN1)os44 line was used for further experiments and is hereafter referred to as Tg(mnx1:RFP-SMN). We also generated a transgenic zebrafish line expressing human SmB (16) . Sm proteins are part of the snRNP complex and bind to SMN (17) . Analysis of cultured neurons revealed that unlike SMN, Sm proteins were not found in axons (8, 11, 18, 19) and thus were used as a control in this study. To this end we generated a transgenic line driving GFP-SmB under the zebrafish mnx1 promoter Tg(mnx1:1.5hsp70:GFPSmB)os48 hereafter referred to as Tg(mnx1:GFP-SmB) (Fig. 1 C, D) .
RFP-SMN is present in motor axons only during the period of robust axon outgrowth and arborization
Although SMN is a protein that translocates between the nucleus and the cytoplasm and is important for splicing fidelity (20, 21), numerous reports have found SMN in axons in vitro and in fixed tissue from rat and human (reviewed in 22). Therefore, we by guest on November 7, 2016 http://hmg.oxfordjournals.org/ Downloaded from 6 first asked where RFP-SMN was localized in motoneurons in vivo during development.
All three transgenic lines expressed RFP-SMN at high levels in motoneuronal cell bodies as expected since we were using the mnx1 promoter (Fig. 2) . However, RFP-SMN was also present in motor axons in all three lines at 1 dpf. Although all three lines had different expression levels (Fig. 1B) yet all showed RFP-SMN in motor axons, we wanted to ensure that we weren't forcing expression in axons due to overexpression. Therefore, we analyzed the Tg(mnx1:GFP-SmB) line in a similar manner. Consistent with data from cultured neurons, we found that when we expressed SmB in motoneuronal cell bodies, it was not detected in motor axons (Fig. 2) . These data support that SMN is indeed localized to motor axons.
We next asked whether this localization pattern changed during development.
Motor axons undergo robust arborization and branching during the first few days of development (23, 24). To quantitate this growth, we labeled single individually identified Caudal Primary motoneurons (CaPs) with GFP using an mnx1:GFP DNA construct that stochastically labels individual motoneurons (7, 25) (see methods) and imaged the same motoneuron from 2 -8 dpf then measured the total length of the axonal branches.
At 1 dpf CaP axons have very few branches (data not shown), however numerous branches are present at 2 dpf (Fig. 3 A, B) . We found that there was an approximately 3-fold increase in the total branch length between 2 and 4 dpf (255 ± 79 µm versus 742±125 µm). However, no significant change in total branch length was observed at 6 (910± 139 µm) and 8 (874±134 µm) dpf respectively (Fig. 3A, B) . We then analyzed RFP-SMN localization between 2 and 8 dpf. Florescence density was measured over a 60 µm (Fig. 3 C, D) . These data show that SMN is present in axons at 1-2 dpf during the period of robust axonal growth and branching, but decreases once the branches have been established.
Expressing SMN in motoneurons does not extend survival of mz-smn mutants
We have previously generated maternal:zygotic smn mutants (mz-smn) that lack both maternal and zygotic zebrafish Smn, but express low levels of human RFP-SMN as they carry the leaky transgene, Tg(1.5hsp70:RFP-Has.SMN)os36, in their background (7). These will be referred to here as mz-smn mutants. Survival analysis revealed that these fish lived 9.7 ± 1.9 days (n=19) consistent with our original report (7). This same and dendrite defects indicating that their motoneurons were not developing normally (7).
We also showed that these defects could be rescued by expressing SMN throughout the embryo soon after motoneurons were born (~10 hpf (Fig.4 A-D (Fig. 4 E-G) revealed that motor axonal projections in mutants lacked robust secondary and tertiary branches and that this was rescued when RFP-SMN was expressed just in motoneurons (Fig. 4 H) . We also examined dendrite development at 4 dpf and found that expressing RFP-SMN just in motoneurons rescued the defects seen in mz-smn −/− (Fig. 5) . Thus, SMN is needed cell autonomously for key aspects of motoneuron development. (Fig. 6) . We found in mz-smn mutants that although the Schwann cells migrated and associated with motor nerves, they did not form a tight association and appeared to remain loosely wrapped (Fig. 6 A-F) . To analyze this in more detail, we examined the nodes of Ranvier using the antibody anti- Together, these data conclusively demonstrate that Schwann cell defects occur in animals expressing low levels of Smn, and that this is secondary to the developmental defects in motoneurons in these animals.
Expressing SMN in motoneurons rescues
10
DRG are affected in mz-smn mutants
Analysis of mouse models of SMA suggested that the proprioceptive sensory afferents onto motoneurons were decreased indicating that there may be peripheral nervous system (PNS) defects in these animals (30, 31). To determine whether PNS defects were present in mz-smn −/− animals, we examined DRG, sympathetic ganglia, and enteric neurons. To examine the peripheral nervous system neurons, we analyzed HuC/D antibody labeling at 8 dpf and examined DRG, sympathetic ganglia neurons and enteric neurons (32, 33) ( 
DRG peripheral axons are rescued by expressing SMN in motoneurons
To examine the DRG defect in more detail, we used a transgenic zebrafish, Tg(neurog1:EGFP), that expresses GFP in DRG neuronal precursors as they migrate ventrally and after they differentiate into neurons (34). Using this line, we were able to track the fate of DRG neuronal precursor cells during their specification and differentiation. We crossed this line into the mz-smn mutants and found that DRG neurons were born and migrated normally, however, close to half of the DRG neurons examined did not form a normal peripheral axon. At 2 dpf, 94% of DRG in wild-type embryos formed a long peripheral axon, but only 55.5% mz-smn We also examined DRG cell number and found that the aberrant outgrowth of DRG peripheral axons in mz-smn mutants was followed by a failure to generate more DRG neurons in the ganglia resulting in fewer neurons compared to wild-types at the same age ( Fig. 10) . At 2 dpf, all three groups had on average 1 cell per ganglion (Fig. 12 
B, G, H). In mz-smn
-/-larvae, however, there was not an increase, but rather a decrease in DRG neurons with some segments having only 1 neuron and other segments lacking DRG neurons all together (Fig. 10 D, G, H) . This defect was completely rescued by driving RFP-SMN in motoneurons (Fig. 10 E-H) . HuD/C antibody labeling also clearly showed that RFP-SMN driven by the mnx1 promoter was not expressed in DRG neurons ( Fig. 10 E, F see also Fig. 11 D) . These data support that the DRG defects are non-cell autonomous and dependent on normal motoneuron development.
To better understand why normal motoneuron development is important for DRG neurons, we analyzed cross sections in double transgenic lines with antibody labeling to visualize both motor axons and DRG peripheral nerve (Fig. 11 ). This analysis shows that the DRG peripheral axon extends along the same region as ventrally extending motor axons. It appears, therefore, that a normal motor axon is necessary for the latter extending DRG peripheral axon to extend properly to its target skin.
Discussion
We have used a genetic model of SMA in zebrafish to explore how low levels of SMN effects motoneuron development. By combining mutants with spatial transgenics, we show that SMN expression in motoneurons is required for proper motoneuron development. In addition, low levels of SMN throughout the animal results in other deficiencies such as poor Schwann cell motor axon wrapping and loss of DRG peripheral axons and subsequent loss of DRG cell bodies. These phenotypes are also rescued by expressing SMN in motoneurons indicating that they are non-cell autonomous. Thus, poor motoneuron development due to low levels of SMN can cause Studies in Drosophila showed that driving SMN in interneurons, not motoneurons, rescued the motor circuit defect in smn mutants (35). Interestingly, these interneurons are cholinergic and the motoneurons in Drosophila are glutamatergic raising the possibility that there may be something unique about the need for SMN in cholinergic neurons. We had previously shown in zebrafish smn zygotic mutants that driving human SMN in motoneurons can rescue presynaptic neuromuscular junction (NMJ) defects (36). Subsequent mouse studies also showed that expressing SMN in motoneurons rescues NMJ defects (37, 38) . Together these data support that at least in vertebrates (zebrafish, mouse) SMN acts cell-autonomously in motoneurons for both their development and NMJ formation and maintenance.
The finding that driving SMN only in motoneurons does not rescue survival supports that SMN is needed in motoneurons for proper motoneuron development, but that it is needed elsewhere to support survival of the animal. The first indication of this came from work showing that driving SMN with the prion promoter, with expression in the nervous system and low expression in muscle, rescues SMA mouse models (39) .
The prion promoter expresses in neurons throughout the CNS with the exception of cerebellar Purkinje neurons (40, 41) . However, less is known about its expression in the spinal cord and peripheral nervous system. Thus, there are other cells in the nervous system that need to express SMN for animal survival. Subsequent studies showed that driving SMN in an SMA mouse model using the pan-neuronal nestin promoter increased survival 4-fold, but not completely (42). Studies in Drosophila are consistent with the mouse data and showed that a pan-neuronal driver of SMN rescued survival of smn by guest on November 7, 2016 http://hmg.oxfordjournals.org/ Downloaded from mutants (35). Studies have also shown that decreasing SMN in motoneurons causes SMA phenotypes, but these are not as severe as when SMN levels are low throughout the animal (43). In reciprocal experiments, it was shown that increasing SMN in motoneurons in SMA mice using the choline acetyl transferase (ChAT) promoter and the mouse hb9 (mnx1) promoter rescued motoneurons, but only had a modest affect on survival (37, 38) . We had previously shown using conditional transgenics, that both motoneuron development and survival could be rescued by adding SMN back via a heatshock promoter at 10 hpf (7). However, survival, but not motoneurons, could be rescued by adding SMN back at 24 hpf and neither motoneurons or survival could be rescued by adding SMN back at 36 hpf. Collectively, these data indicate that rescuing motoneurons alone is not enough to rescue animal survival supporting that SMN is critical in other cells with most data indicating that these cells are in the nervous system. Moreover, our zebrafish experiments also indicate the need for SMN in motoneuron development occurs temporally before the need for SMN for survival.
In this present study we have focused specifically on motoneuron development. This is relevant because SMN levels are low throughout development and if motoneuron development is negatively impacted, then it will affect subsequent motor circuit formation and motor function. This is supported by our previous experiments showing that zebrafish with defective motor axons exhibit movement defects (7). How this would affect motor function is not clear, however, the motor deficit we see in the mz-smn fish could be caused in part by this defect in addition to the decreased synaptic input onto the muscles as a result of fewer axonal arbors.
Our data show that poorly developed motoneurons affect the ability of the DRG peripheral axon to reach the skin leading to DRG cell loss due to lack of target derived trophic support. One explanation for this could be because motor axons act as a scaffold for the DRG peripheral axon. In zebrafish motor axons extend along the medial muscle starting at approximately 18 hpf and by 2 dpf there are numerous axons that fasciculate to form a nerve (23, 24). At 2 dpf the DRG peripheral axon is extending along the same region of the medial muscle. Thus, it is possible that the motor nerve in mz-smn mutants is not a robust substrate for the DRG peripheral axon thus hindering its ability to extend out to the skin. Data from SMA mouse models have shown that there are less propriopceptive glutamatergic synapses onto motoneurons (30, 31, 43). One explanation is that the afferents onto the motoneurons are affected or alternatively that the motoneuron is a poor target due to its deficits resulting in decreased presynaptic input. To test this, SMN was driven in motoneurons using the mouse hb9/mnx1 promoter and this was shown to rescue the glutamatergic synapses (37) . It was also shown that contacts from the same muscle spindle sensory afferents onto nonmotoneuron Renshaw cells were normal indicating that the target, not the inputs, were affected in SMA mice (45). These data illustrate that cells that come into contact with poorly developed motoneurons, either by sharing a common pathway or as synaptic partners, may be secondarily affected.
To better understand the function of SMN in neurons, we wanted to determine whether SMN was in axons in vivo. However, it is problematic to visualize endogenous protein expression in axons. Axons are thin, these proteins are often dynamic and endogenous proteins cannot be observed without fixing the animals and performing antibody labeling making it impossible to follow expression over time. It is also very difficult to visualize endogenous SMN localization due to its faint, punctate expression in all cells. By expressing tagged proteins, we circumvent these problems. The three
Tg(mnx1:SMN-RFP) lines we generated show consistent patterns of expression and
were not grossly overexpressing the tagged proteins. We also used a control line that expresses SmB, which is a protein that forms a complex with SMN facilitating snRNP assembly (17) . This protein is not expressed in cultured motor axons (8, 11, 18, 19) and indeed the tagged protein is limited to the cell soma in our transgenics. Moreover, SMN-RFP, while present in the cell soma at all times, is present in axons at 1-2 days, but not at 4 dpf and older. This supports that we are not just forcing expression in axons, but that the tagged protein is dynamic and regulated. In cultured neurons both endogenous and expressed SMN are present in motor axons and both endogenous and expressed SmD is limited to the cell soma (8, 11). Taken together, these data support that tagged, expressed proteins can be used to study dynamic protein localization in axons in vivo.
To our surprise, however, SMN was only present at detectable levels in axons in vivo during the period of robust motor axon outgrowth and arborization. Three separate 
Material and methods
Zebrafish maintenance
Zebrafish used in this study were on the *AB/TL (Tupfel long fin) background. temperatures between 27 and 29°C and maintained by standard protocols (50) .
Nomenclature
Gene and protein nomenclature conform to species conventions (51). Zebrafish gene or RNA is denoted as lowercase italics, smn, and protein as Smn. The human gene or RNA is uppercase italics, SMN, and protein, SMN. When speaking of the protein or RNA in the general sense, the human convention is used.
DNA constructs used for making transgenic lines
mnx1:hsp70:RFP-hSMN construct.
The RFP-hSMN (52) in pCS2 was digested with BamHI and NotI and cloned into pBluescript vector that contained mnx1/hb9 promoter (14) and two SceI sites as previously described (53, 54) to generate mnx1:RFP-hSMN/pBluescripSceI plasmid. To enhance expression from the mnx1 promoter, 1.5 kb of the heat shock 70 promoter (hsp70) was released from the pHSP70/4 EGFP-1 plasmid (55) using the BamHI site and cloned into the mnx1:RFP-hSMN/pBluescripSceI plasmid. The orientation of the hsp70 promoter was determined by injecting DNA into one-cell embryos followed by heat shocking at day 1 (30 minutes at 37°C) and screening for RFP-SMN at day 2. The mnx1:hsp70: RFP-hSMN/pBluescriptSceI that gave an RFP signal in motoneurons and expressed RFP-SMN throughout the embryos after heat shock was used to make transgenic lines Tg(mnx1:1.5hsp70:RFP-SMN)os44 and 45 as described below.
mnx1:0.6Hsp70: RFP-hSMN construct.
The last 600 base pair of the 1.5 kb heat shock 70 promoter (56) (hsp70) was PCR amplified from the pHSP70/4 EGFP-1 plasmid using forward primer 
Generating transgenic lines
DNA injections and identification of transgenic F1 founders was performed as previously described (57). If required, upon reaching adulthood they were crossed to 
Western blotting
Western blots were performed as previously described (57 
Transient DNA injections for axon and dendrite measurements
Transient DNA injections and axon and dendrite measurements were performed as previously described (7).
Electron microscopy
Electron microscopy was performed at the Ohio State University Campus Microscopy and Imaging Facility. Briefly, embryos at 6 dpf were fixed in 6% glutaraldehyde in PBS for overnight at 4°C. Head, yolk sac, yolk extension and most of the tail fin were removed within the first minutes of fixation to allow better penetration of the fixative.
Trunks were post fixed in 1% osmium tetroxide in 0.1M Phosphate buffer, en bloc stained with 2% uranyl acetate (aq) for 1 h, dehydrated in a graded series of ethanol and embedded in Eponate12. Sections were cut on a Leica EM UC6 ultramicrotome reported (n = 12 motoneurons analyzed per group, mean ± SD). *** p < 0.0001, **p < 0.005. Two-tailed Student's t-test was used to determine significance. Scale bar, 10 µm.
Arrows denote axons, arrowheads denote dendrites. hemisegments/larvae (mean ± SD). Two-tailed Students t-test was used to determine significance, ***p<0.0001. Scale bar, 20 μm.
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